<DOC>
	<DOCNO>NCT01067001</DOCNO>
	<brief_summary>To determine single-dose oral bioequivalence Minocycline HCl Extended Release Tablets 135 mg manufacture Amneal Pharmaceuticals Co. ( I ) Pvt . Ltd. , India SOLODYN® ( minocycline hydrochloride ) Extended Release Tablets 135 mg Manufactured Medicis , The Dermatology Company , Scottsdale , AZ 85256 , Wellspring Pharmaceutical Canada Corp. , Oakville , Ontario L6H 1M5 normal , healthy , adult , human subject fast condition .</brief_summary>
	<brief_title>Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study</brief_title>
	<detailed_description>Subjects fast least 10 hour prior schedule time dose . As per randomization schedule , one tablet test reference product administer subject 240 mL water ambient temperature period . Twenty four sample collect subject period . The venous blood sample ( 5 mL ) withdrawn pre-dose ( dose , morning day dose ) 1.00 , 2.00 , 2.50 , 3.00 , 3.25 , 3.50 , 3.75 , 4.00 , 4.25 , 4.50 , 5.00 , 5.50 , 6.00 , 7.00 , 8.00 , 10.00 , 12.00 , 16.00 , 24.00 , 48.00 , 72.00 , 96.00 , 120.00 hour dose . The sample collect 48.00 , 72.00 , 96.00 , 120.00 hour dose ambulatory basis ( i.e . separate visit ) . After collect blood sample subject sampling time point , sample centrifuge refrigeration machine set 3000 rpm , 10 minute 4oC . After centrifugation , plasma sample separate transfer respective prelabeled polypropylene tube . These polypropylene tube store -20°C maximum period 12 hour store -70°C ± 20°C withdrawn analysis . Samples subject complete period study per approve protocol analyze .</detailed_description>
	<criteria>Healthy human subject age 18 45 year . ( include ) Subjects BMI 18.5 24.9 Kg/m2 ( include ) body weight less 45 Kgs . Subjects normal health determine personal medical history , clinical examination , laboratory examination include serological test Subjects normal 12lead electrocardiogram ( ECG ) . Subjects normal chest XRay ( P/A view ) . Subjects able communicate effectively . Subjects willing give write informed consent adhere requirement protocol . Female subject postmenopausal surgically sterile . Female subject practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) abstinence . Subjects contraindication hypersensitivity minocycline relate group drug . History presence medical condition disease accord opinion physician . History presence significant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , endocrine , immunological , dermatological , neurological psychiatric disease disorder . History presence significant alcoholism drug abuse past one year . History presence significant smoking ( 10 cigarette bidis/day consumption tobacco product ) . Difficulty donate blood . Difficulty swallow solid like tablet capsule . Systolic blood pressure le 90 mm Hg 140 mm Hg . Diastolic blood pressure le 60 mm Hg 90 mm Hg . Pulse rate le 50 beats/minute 100 beats/minute . Use prescribed medication last two week OTC medicinal product last one week precede first dosing . Major illness 3 month screen . Participation drug research study within past 3 month . Donation blood past 3 month screen . Female subject demonstrate positive pregnancy screen . Female subject currently breastfeed . Female subject child bear potential use prohibit contraceptive method ( Oral , Injectable Implantable hormonal agent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>